5 Migraine Clinical Trials in Walnut Creek, CA (2026)

Q: How do I join a clinical trial in Walnut Creek?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you.

Recruiting Migraine Studies in Walnut Creek

NCT06641466Recruiting

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience ...

Walnut Creek, CAPHASE3723 participantsPfizer

View Study Details

NCT05711394Recruiting

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other sy...

Walnut Creek, CAPHASE3450 participantsAbbVie

View Study Details

NCT06810505Recruiting

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to...

Walnut Creek, CAPHASE3420 participantsAbbVie

View Study Details

NCT07646613Recruiting

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medicat...

Walnut Creek, CAPHASE2108 participantsAspeya, Inc.

View Study Details

NCT06735833Recruiting

MMA Embolization for Refractory Chronic Migraine

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the tr...

Walnut Creek, CANA70 participantsCerenovus, Part of DePuy Synthes Products, Inc.

View Study Details

About Migraine Clinical Trials in Walnut Creek

Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.

There are currently 5 migraine clinical trials recruiting participants in Walnut Creek, CA. These studies are seeking a combined 1,771 participants. Research is being sponsored by Pfizer, AbbVie, Aspeya, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Migraine Clinical Trials in Walnut Creek — FAQ

Are there migraine clinical trials in Walnut Creek?

Yes, there are 5 migraine clinical trials currently recruiting in Walnut Creek, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Walnut Creek?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Walnut Creek research site will contact you about next steps.

Are clinical trials in Walnut Creek free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Walnut Creek studies also compensate for your time and travel.

What migraine treatments are being tested?

The 5 active trials in Walnut Creek are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.

Data updated July 18, 2026 from ClinicalTrials.gov